Oct 02, 2019 / 01:00PM GMT
Presentations - Conference Call
Oct 02, 2019 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Anne E. White
Eli Lilly and Company - Senior VP & President of Lilly Oncology
* Daniel M. Skovronsky
Eli Lilly and Company - Senior VP & Chief Scientific Officer
* Jacob S. Van Naarden
Loxo Oncology, Inc. - COO
* Kim Macko
* Martin Frenzel
* Maura Dickler
* S. Michael Rothenberg
=====================
Conference Call Participants
=====================
* Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
* Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
* Seamus Christopher Fernandez
Guggenheim Securities, LLC, Research Division - Senior Analyst of Global Pharmaceuticals
* Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Eli Lilly and Co
(HAM:LLY0)
€
25
-2 (-7.41%)
Market Cap: 930.72 Bil
Enterprise Value: 964.17 Bil
PE Ratio: 42.22
PB Ratio: 34.04
GF Score: 96/100 Eli Lilly and Co to Discuss ESMO 2019 Presentations - Conference Call Transcript
Oct 02, 2019 / 01:00PM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot